For example, a biomarker such as KIM-1, found to have a potentially significant capability of predicting CKD in a non-leptospirosis study21,58, could be used to monitor the development of CKD in patients with leptospirosis. This evidence concerns the gene HAVCR1 and chronic kidney disease.